/ 2 items

#HIMS↓

GDRX/ 08/18/2025 · 11:14 AM

GoodRx & Novo Nordisk Unlock GLP-1 Access

GoodRx partnered with Novo Nordisk to offer Ozempic and Wegovy pens for $499/month to self-paying patients, expanding access for those without adequate insurance. This makes them available at over 70,000 U.S. pharmacies. Hims & Hers down.

HIMS/ 08/04/2025 · 5:25 PM

Hims & Hers Q2: Profit Soars, Revenue Miss Sparks Share Drop

Hims & Hers' Q2 profit surged to $42.5M, fueled by 31% subscriber growth (2.4M total). Revenue of $544.8M missed estimates, impacted by wholesale weakness, causing shares to fall. Full-year guidance maintained.